Clinical Trial Update: Pediatric Nevirapine Resistance Study [Phase 3]

View source ↗

Summary

Phase 3 pediatric study evaluating nevirapine resistance in HIV/AIDS patients; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: AIDS, HIV Infections | Phase 3 | Status: UNKNOWN